Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Caring Brands, Inc. - Common Stock
High-Trend International Group - Class A Ordinary Shares
Senstar Technologies Corporation - Common Shares
Valor Energy Incorporated - Common Stock
VisionSys AI Inc. - American Depositary Shares
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Path Holdings, Inc. - Common Stock
(NQ:
BPTH
)
0.2100
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Path Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 02, 2023
Via
Benzinga
Bio-Path Releases Early Cut Data From Mid-Stage Prexigebersen Trial In Acute Myeloid Leukemia
↗
August 01, 2023
Bio-Path Holdings Inc (NASDAQ: BPTH) reported interim data from Stage 2 of the company's Phase 2 study of prexigebersen in combination with decitabine and venetoclax for
Via
Benzinga
Bio-Path Holdings Announces Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia
August 01, 2023
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Earnings Preview
↗
May 11, 2023
Via
Benzinga
A Preview Of Bio-Path Holdings's Earnings
↗
March 30, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 19, 2023
Via
Benzinga
Bio-Path Holdings Announces Successful Completion of First Dose Cohort in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
July 17, 2023
Advancing to Second Cohort of Phase 1/1b Clinical Trial Evaluating BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 26, 2023
Via
Benzinga
Why Is FibroGen (FGEN) Stock Down 81% Today?
↗
June 26, 2023
FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint.
Via
InvestorPlace
Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?
↗
June 26, 2023
MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial.
Via
InvestorPlace
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Why Is Bio-Path (BPTH) Stock Down 12% Today?
↗
June 26, 2023
Bio-Path (BPTH) stock is sliding lower on Monday after the biotechnology company announced a proposed public share offering.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 26, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 26, 2023
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 23
June 02, 2023
Dallas, Texas--(Newsfile Corp. - June 2, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate...
Via
Newsfile
Earnings Scheduled For May 12, 2023
↗
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
Bio-Path Holdings Reports First Quarter 2023 Financial Results
May 12, 2023
Conference Call to be Held Today at 8:30 A.M. ET
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023
May 05, 2023
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22
April 10, 2023
Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The...
Via
Newsfile
Bio-Path Holdings Reports Full Year 2022 Financial Results
March 31, 2023
Conference Call to be Held Today at 8:30 A.M. ET
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023
March 24, 2023
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Provides Clinical and Operational Update
March 16, 2023
Company Expects to Achieve Several Near-Term Clinical Milestones
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 09, 2023
Via
Benzinga
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 '22
December 19, 2022
Dallas, Texas--(Newsfile Corp. - December 19, 2022) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners updates coverage on Bio-Path...
Via
Newsfile
Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
December 07, 2022
Phase 1/1b Clinical Trial Evaluating Ability of BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Q3 2022 Earnings Conference Call On November 15, 2022 At 08:30 AM ET
↗
December 06, 2022
Bio-Path Holdings (NASDAQ:BPTH) will host a conference call at 08:30 AM ET on November 15, 2022, to discuss Q3 2022 earnings results. How to Attend Bio-Path Holdings (BPTH) Conference Call Follow this...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.